Key takeaways:
Breast cancer is usually treated with surgery, radiation therapy (RT), and/or medications.
Common breast cancer medications include chemotherapy, targeted therapy, immunotherapy, and hormone therapy.
There isn’t a “best” medication for breast cancer — the best options depend on your situation.
Breast cancer is the second most common type of cancer in the U.S. for women. Over the decades, pharmaceutical companies, researchers, and other groups have invested time, effort, and money into developing many breast cancer treatment options.
Compared to the first breast cancer surgery performed all the way back in 1882, today there are several tools and strategies that cancer specialists can choose from to treat breast cancer. In addition to surgery and radiation therapy (RT), there are a large number of FDA-approved medications that can help prevent or treat breast cancer.
But, with so many medications available today, it can be hard to keep track of the different ones that are available.
In this article, we’ll list out and briefly describe different medications that can be used to prevent or treat breast cancer.
Cancer is complicated. Breast cancer treatments are unfortunately no exception. Depending on the type, severity, and other characteristics of someone’s cancer, an overall treatment strategy can change.
But, no matter the specifics, breast cancer is usually treated with surgery, RT, and/or medications.
Surgery: Many people with non-metastatic breast cancer undergo surgery to remove their tumor (cancer). There are different types of breast cancer surgery, including surgeries that can remove part of the breast or the entire breast. RT and medications — both mentioned below — can be used before or after surgery to improve the chances of successfully treating a tumor.
Radiation: RT uses energy — from sources like x-rays and gamma rays — to shrink tumors and kill cancer cells.
Chemotherapy: Chemotherapy medications are anti-cancer treatments that directly fight and kill cancer cells. Not every person with breast cancer needs chemotherapy, but it’s one of the most common forms of treatment. Although it’s often effective, it can cause a lot of side effects.
Hormone (endocrine) therapy: In many cases, breast cancer can be especially sensitive to the amount of estrogen and progesterone in the body. These natural hormones can act as fuel for a tumor and cause the cancer to grow. Hormone therapy medications work to block estrogen or progesterone to help control this growth.
Targeted therapy: Targeted therapy medications work by seeking out specific molecules or genes that are thought to be involved in the growth and spread of cancer.
Immunotherapy: Ultimately, a functioning immune system is a key component of keeping us healthy. But, the immune system sometimes needs a boost so it can more effectively fight cancer. Immunotherapy medications — technically a type of targeted therapy — can help strengthen our immune system’s response to cancer.
Supportive care: Cancer — and different treatments used to treat cancer — can cause quite a few side effects. Supportive care treatments help control how bad cancer-related symptoms are. Medications used to control nausea, pain, or anxiety are examples of supportive care treatments. These aren’t specifically discussed in this article.
Spoiler alert — there isn’t one best medication for treating breast cancer. Depending on the severity and type of breast cancer, many medications can be used. Sometimes only one medication is needed, but often, multiple medications are used.
Selecting medication(s) to treat breast cancer is a very variable decision based on your situation — your cancer specialist can tell you what option(s) may be best for you. But, it’s likely that they may choose from one or more of the options discussed next.
Of note, only single-ingredient medications are mentioned in the tables below. Several of the medications are also available as combination products.
Chemotherapy is often used before surgery to shrink a tumor, after surgery to kill cancer cells that were potentially left behind after a tumor removal, or to treat more advanced forms of breast cancer. Chemotherapy can be used alone or in combination with RT, other chemotherapies, or other cancer medications.
Chemotherapy is typically given at a hospital or a cancer center, and usually infused into a vein. Although these medications are used for a reason — they’re often effective — they can cause a number of harmful side effects.
Like mentioned, chemotherapy medications work by targeting cancer cells directly. But, they don’t know to only target cancer cells. Unfortunately, they’re potentially harmful because they can also affect normal parts of our bodies, such as our hair, mouth, and internal organs.
Chemotherapy medications used to treat breast cancer are discussed in a recent GoodRx article. To learn more, click or tap here.
Chemotherapy was the first category of breast cancer medications, and many people still think of it as the best or only treatment option. But there are actually a number of other cancer medications that aren’t chemotherapy.
As the years have gone on, researchers’ main focus has shifted from chemotherapy to targeted therapy. Many cancers can be caused by genetic mutations or an excessive growth of certain proteins, so if these changes are directly targeted, it’s thought that there may be a better chance for a successful treatment.
FDA-approved targeted therapies for breast cancer are mentioned in the table below. Some of these medications — especially infusion-based medications — are only given at a hospital or cancer center. Others can be dispensed at a specialty pharmacy or retail pharmacy.
Medication | How is it given? | What does it target in the body? |
---|---|---|
Abemaciclib (Verzenio) | Oral tablet | CDK 4/6 are enzymes (proteins) that are often involved in the growth and spread of cancer cells. Sometimes, these enzymes can get out of control and lead to cancer growth. Abemaciclib is a medication that aims to stop this excessive growth by stopping CDK 4/6. |
Palbociclib (Ibrance) | Oral capsule, tablet | Similar to abemaciclib (more information) |
Ribociclib (Kisqali) | Oral tablet | Similar to abemaciclib (more information) |
Lapatinib (Tykerb) | Oral tablet | Some breast cancers have an abundance of EGFR and/or HER2. EGFR is a receptor (chemical binding site) on some breast cancer cells, and too much EGFR can lead to cancer growth and progression. HER2 is a protein on all breast cells. On cancerous cells, too much of it can lead to faster growth compared to other types of breast cancer. Lapatinib aims to stop the intentions of both EGFR and HER2. |
Neratinib (Nerlynx) | Oral tablet | Similar to lapatinib (more information) |
Tucatinib (Tukysa) | Oral tablet | Tucatinib targets HER2, similarly to lapatinib, but it doesn’t target EGFR. |
Everolimus (Afinitor, Afinitor Disperz) | Oral tablet, suspension | mTOR is an enzyme that is involved in cell growth. In some breast cancers, the chemical pathway that mTOR is a part of can malfunction. This can lead to breast cancer growth. Everolimus aims to stop mTOR’s function. |
Alpelisib (Piqray) | Oral tablet | PI3K is an enzyme that lives in the same chemical pathway as mTOR, mentioned above. When PI3K stops working properly — or if it’s too abundant — it can lead to breast cancer growth.] Alpelisib aims to stop PI3K’s function. Through a complex mechanism, it can also help improve the effectiveness of some hormonal cancer treatments. |
(Lynparza) | Oral tablet | PARP is an enzyme that helps repair damaged DNA (deoxyribonucleic acid). While PARP is usually helpful, it’s not ideal when PARP helps cancer cells repair themselves. Olaparib is a medication that stops cancer cells from using PARP, thus causing them to die from unrepaired damage. |
Talazoparib (Talzenna) | Oral capsule | Similar to olaparib (more information) |
Sacituzumab govitecan (Trodelvy ) | IV infusion | Trop-2 is a protein more commonly found in cancer cells compared to normal cells. Sacituzumab helps target cancer cells that contain Trop-2. It’s attached to another molecule that helps destroy these cancer cells. |
A cancer specialist can run lab or genetic tests to determine if breast cancer may respond to one or more of the targets mentioned above.
Many people think of immunotherapy, or immune targeted therapy, as a unique type of cancer treatment. But, it’s technically a type of targeted therapy.
Regardless of how they’re classified, immunotherapy medications help strengthen — or empower — the immune system to more effectively fight cancer. These medications are often used in addition to chemotherapy, but they can also be used by themselves.
Medication | How is it given? | How does it help the immune system fight cancer? |
---|---|---|
Pembrolizumab (Keytruda) | IV infusion | PD-1 is a protein that can live on the surface of our T cells (immune system cells that can attack cancer cells). When PD-1 combines with a receptor (chemical binding site) called PD-L1 on the surface of certain cancer cells, the combination can tell your immune system to ignore cancer cells. Pembrolizumab can stop this interaction and help your immune system kill cancer cells. |
Atezolizumab (Tecentriq) | IV infusion | PD-L1 is a receptor (chemical binding site) on certain cancer cells. When PD-1, mentioned above, combines with PD-L1, the combination can tell your immune system to ignore cancer cells. Atezolizumab, in a slightly different way than pembrolizumab, can stop this interaction and help your immune system to kill cancer cells. |
Trastuzumab (Herceptin, others) | IV infusion |
Like mentioned above, HER2 can lead to accelerated breast cancer growth. Trastuzumab targets HER2. But, trastuzumab takes this targeting a step further. Trastuzumab also helps the immune system find and kill cancer cells that are covered by a lot of HER2 proteins. |
Ado-trastuzumab emtansine (Kadcyla) | IV infusion | Similar to trastuzumab (more information) |
Fam-trastuzumab deruxtecan (Enhertu) | IV infusion | Similar to trastuzumab (more information) |
Pertuzumab (Perjeta) | IV infusion | Similar to trastuzumab (more information) |
Margetuximab (Margenza) | IV infusion | Similar to trastuzumab (more information) |
In addition to chemotherapy, targeted therapy, and immunotherapy, there are other medications that can be used to treat breast cancer.
Like mentioned, many breast cancers are sensitive to estrogen or progesterone. Estrogen is a common fuel source for breast cancer cells, so hormonal therapy medications can cut off this fuel source by lowering the amount of estrogen in the body. Some hormonal therapies are specifically intended for people who have gone through menopause, while others are not.
Also, when breast cancer spreads (metastasizes), it can go to other parts of the body, most commonly the bones. Some medications can help prevent bone loss and treat bone metastases.
Medication | How is it given? | How does it help treat breast cancer? |
---|---|---|
Anastrozole (Arimidex) | Oral tablet | For certain people who have gone through menopause, anastrozole helps lower the amount of estrogen in the body so it can cut off the cancer’s estrogen access. |
Exemestane (Aromasin) | Oral tablet | Similar to anastrozole (more information) |
Fulvestrant (Falsodex) | Injection into the muscle (IM) | Similar to anastrozole (more information) |
Letrozole (Femara) | Oral tablet | Similar to anastrozole (more information) |
Goserelin (Zoladex) | Subcutaneous implant | For certain people who haven’t gone through menopause, goserelin stops the ovaries from making estrogen. |
Leuprolide (Lupron Depot) | IM injection | Similar to goserelin (more information) |
Megestrol | Oral tablet | For certain people with advanced breast cancer, megestrol can help lower estrogen levels. |
Methyltestosterone (Methitest) | Oral capsule, tablet | For certain people who have gone through menopause, methyltestosterone can help lower estrogen levels. |
Tamoxifen (Soltamox) | Oral liquid, tablet | For many people with breast cancer, tamoxifen can help by helping stop estrogen from getting to the breast tissue. |
Toremifene (Fareston) | Oral tablet | For many people with metastatic breast cancer, toremifene can help by helping stop estrogen from getting to the breast tissue. |
Denosumab (Prolia, Xgeva) | Subcutaneous (under the skin) injection |
Helps prevent bone loss in people receiving an aromatase inhibitors (AI) (Prolia).
Treats cancer that has spread to the bone (Xgeva). |
Pamidronate (Aredia) | IV infusion | Similar to Xgeva (more information) |
Zoledronic acid (Zometa) | IV infusion | Similar to Prolia (off-label use — more information) |
There are two medications that can help lower the chances of developing breast cancer. These two medications — raloxifene (Evista) and tamoxifen — can help lower the risk by up to 40%, depending on your situation.
Raloxifene and tamoxifen work in a unique way — they act like estrogen in some areas of the body, but they stop estrogen from working in other areas of the body. They can stop estrogen from getting to breast tissue and this can lower the risk of developing breast cancer.
Medication | How is it given? | How does it help prevent breast cancer? |
---|---|---|
Raloxifene | Oral tablet | For women who are at high risk of getting breast cancer, raloxifene can help stop estrogen from getting to the breast tissue. |
Tamoxifen | Oral liquid, tablet | Similar to raloxifene (more information) |
Unfortunately, there’s not a great answer for this. It’s highly dependent on the situation. Some medications are taken for just a few months, and others may be taken for up to 10 years.
For example, chemotherapy is usually given in rounds (cycles). One cycle often lasts one month, but it can be shorter or longer depending on the person and medications being used. Sometimes cycles are prescribed for a set time frame — such as 6 cycles lasting for 6 months — but sometimes they’re given indefinitely until the medication(s) stop working.
By comparison, hormonal therapies — like tamoxifen, anastrozole, and exemestane — may be given for up to 5 to 10 years.
There are some general considerations about when you may stop taking a particular medication or switch to another one. These may include:
If your cancer has worsened or progressed
If your treatment is determined to be ineffective by your cancer specialist
If the costs of a medication outweigh its potential benefits
If side effects are too bothersome or severe and outweigh its potential benefits
Depending on the medications, side effects differ considerably. While specific medications have their own unique side effects, there are also general side effects that are commonly seen among groups of cancer medications.
Chemotherapy is widely known for causing side effects. Common side effects of breast cancer chemotherapy may include:
Hair loss
Sores in the mouth and throat
Loss of appetite
Fatigue
Nausea, vomiting, or diarrhea
Higher chance of getting an infection compared to normal
When targeted therapies were initially being developed, it was thought they might have fewer side effects than chemotherapy because they more specifically target cancer cells. But, targeted therapies still have many bothersome side effects. These can include:
Diarrhea
Liver problems
Fatigue
Rashes, dry skin, hair color changes, and other skin problems
Excessive bleeding
Hypertension (high blood pressure)
Hormone therapies can also cause side effects, and they often resemble symptoms of menopause. This is because many of them work by lowering the amount of estrogen in the body.
These are a few possible side effects, but it’s recommended to speak to a pharmacist or cancer specialist to learn more specifics about side effects depending on the medication(s) that you may be receiving.
Surgery, RT, and medications can all be used to treat breast cancer. Chemotherapy, targeted therapy, immunotherapy, and hormonal therapy are all examples of common medications that can be used to treat breast cancer. Although there are different ways to treat breast cancer, the best way to treat it depends on the specific person and type of breast cancer. If you have any questions or concerns about breast cancer treatments, please speak with your cancer specialist.
AbbVie Inc. (2021). Lupron depot [package insert].
Ades, F., et al. (2017). The past and future of breast cancer treatment—From the papyrus to individualised treatment approaches. ecancermedicalscience.
American Cancer Society. (n.d.). Treating breast cancer.
American Cancer Society. (2014). Changes in genes.
American Cancer Society. (2019). How is chemotherapy used to treat cancer?
American Cancer Society. (2021). Breast cancer HER2 status.
American Cancer Society. (2021). Breast cancer risk factors you cannot change.
American Cancer Society. (2021). Chemotherapy for breast cancer.
American Cancer Society. (2021). Hormone therapy for breast cancer.
American Cancer Society. (2021). Tamoxifen and raloxifene for lowering breast cancer risk.
American Health Packaging. (2021). Raloxifene hydrochloride [package insert].
American Pharmacists Association. (n.d.). Specialty pharmacy.
Amgen Inc. (2020). Xgeva [package insert].
Amgen Inc. (2021). Prolia [package insert].
Amneal Pharmaceuticals of New York LLC. (2019). Methyltestosterone [package insert].
AstraZeneca Pharmaceuticals LP. (2021). Lynparza [package insert].
Bosch, A., et al. (2015). PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer. Science Translational Medicine.
Breastcancer.org. (2022). Breast cancer stages.
Breastcancer.org. (2022). Chemotherapy.
Breastcancer.org. (2022). Hormonal therapy.
Breastcancer.org. (2022). Immunotherapy.
Breastcancer.org. (2022). Lumpectomy.
Breastcancer.org. (2022). Radiation therapy.
Breastcancer.org. (2022). Types of breast cancer.
Breastcancer.org. (2022). Types of mastectomy.
Breastcancer.org. (2022). Understanding your pathology report.
Bryant Ranch Prepack. (2021). Megestrol acetate [package insert].
Cancer.net. (2020). Breast cancer: Types of treatment. American Society of Clinical Oncology.
Centers for Disease Control and Prevention. (2021). Breast cancer statistics.
Centers for Disease Control and Prevention. (2021). How is breast cancer treated?
Daiichi Sankyo Inc. (2021). Enhertu [package insert].
Eli Lilly and Company. (2020). Verzenio [package insert].
Endocrine Society. (2022). Reproductive hormones.
Genentech, Inc. (2020). Kadcyla [package insert].
Genentech, Inc. (2020). Perjeta [package insert].
Genentech, Inc. (2021). Herceptin [package insert].
Genentech, Inc. (2021). Tecentriq [package insert].
Gland Pharma Limited. (2021). Zoledronic acid [package insert].
Glenmark Pharmaceuticals Inc., USA. (2021). Fulvestrant [package insert].
Goel, S., et al. (2018). CDK4/6 inhibition in cancer: Beyond cell cycle arrest. Trends in Cell Biology.
Hospira, Inc. (2021). Pamidronate disodium [package insert].
Immunomedics, Inc. (2021). Trodelvy [package insert].
Killock, D. (2017). Leveraging ADCC to enhance anti-HER2 therapy. Nature Reviews Clinical Oncology.
MarcoGenics, Inc. (2021). Margenza [package insert].
Masuda, H., et al. (2012). Role of epidermal growth factor receptor in breast cancer. Breast Cancer Research and Treatment.
Mayne Pharma Inc. (2021). Tamoxifen citrate [package insert].
MedlinePlus. (2021). What is DNA?
Merck Sharp & Dohme Corp. (2021). Keytruda [package insert].
MSN Laboratories Private Limited. (2020). Toremifene citrate [package insert].
National Cancer Institute. (n.d.). Definition of ADCC.
National Cancer Institute. (n.d.). Definition of EGFR.
National Cancer Institute. (n.d.). Definition of endocrine therapy.
National Cancer Institute. (n.d.). Definition of metastasize.
National Cancer Institute. (n.d.). Definition of PARP inhibitor.
National Cancer Institute. (n.d.). Definition of PI3K.
National Cancer Institute. (n.d.). Definition of supportive care.
National Cancer Institute. (n.d.). Definition of T cell.
National Cancer Institute. (n.d.). Definition of treatment cycle.
National Cancer Institute. (n.d.). Definition of tumor.
National Cancer Institute. (2020). Milestones in cancer research and discovery.
National Cancer Institute. (2020). Targeted therapy to treat cancer.
National Cancer Institute. (2021). Advances in breast cancer research.
National Cancer Institute. (2022). Targeted cancer therapies.
National Comprehensive Cancer Network. (n.d.). NCCN Guidelines: Breast cancer.
National Comprehensive Cancer Network. (2022). NCCN Guidelines for Patients: Invasive breast cancer.
Novartis Pharmaceuticals Corporation. (2021). Afinitor/Afinitor disperz [package insert].
Novartis Pharmaceuticals Corporation. (2021). Kisqali [package insert].
Novartis Pharmaceuticals Corporation. (2021). Piqray [package insert].
Novartis Pharmaceuticals Corporation. (2021). Tykerb [package insert].
Ottewell, P., et al. (2019). Bone-targeted agents in breast cancer: Do we now have all the answers? Breast Cancer: Basic and Clinical Research.
Paplomata, E., et al. (2014). The PI3K/AKT/mTOR pathway in breast cancer: Targets, trials and biomarkers. Therapeutic Advances in Medical Oncology.
PD-Rx Pharmaceuticals, Inc. (2021). Anastrozole [package insert].
Pfizer Laboratories Div Pfizer Inc. (2021). Talzenna [package insert].
Proficient Rx LP. (2021). Letrozole [package insert].
Puma Biotechnology, Inc. (2021). Nerlynx [package insert].
Sabatini, D. M. (2017). Twenty-five years of mTOR: Uncovering the link from nutrients to growth. PNAS.
Seagen Inc. (2020). Tukysa [package insert].
TerSera Therapeutics LLC. (2021). Zoladex [package insert].
U.S. Food and Drug Administration. (2020). Frequently asked questions about combination products.
US Pharmaceuticals. (2020). Ibrance [package insert].
Zaman, S., et al. (2019). Targeting Trop-2 in solid tumors: Future prospects. OncoTargets and Therapy.
Zhang, J. Y., et al. (2020). PD-1/PD-L1 based combinational cancer therapy: Icing on the cake. Frontiers in Pharmacology.
Zydus Pharmaceuticals (USA) Inc. (2021). Exemestane [package insert].